Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Sullivan

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Medrxiv : the Preprint Server for Health Sciences|September 10, 2020
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titersEshan U Patel, Evan M Bloch, William Clarke, et al.
Journal of Clinical Microbiology|November 3, 2020
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing TitersEshan U Patel, Evan M Bloch, William Clarke, et al.
The Lancet. HIV|October 2, 2023
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trialMark A Marzinke, Brett Hanscom, Zhe Wang, et al.
The Journal of Infectious Diseases|March 18, 2022
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084Susan H Eshleman, Jessica M Fogel, Estelle Piwowar-Manning, et al.
The New England Journal of Medicine|August 11, 2021
Cabotegravir for HIV Prevention in Cisgender Men and Transgender WomenRaphael J Landovitz, Deborah Donnell, Meredith E Clement, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Medrxiv : the Preprint Server for Health Sciences|September 10, 2020
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titersEshan U Patel, Evan M Bloch, William Clarke, et al.
Journal of Clinical Microbiology|November 3, 2020
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing TitersEshan U Patel, Evan M Bloch, William Clarke, et al.
The Lancet. HIV|October 2, 2023
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trialMark A Marzinke, Brett Hanscom, Zhe Wang, et al.
The Journal of Infectious Diseases|March 18, 2022
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084Susan H Eshleman, Jessica M Fogel, Estelle Piwowar-Manning, et al.
The New England Journal of Medicine|August 11, 2021
Cabotegravir for HIV Prevention in Cisgender Men and Transgender WomenRaphael J Landovitz, Deborah Donnell, Meredith E Clement, et al.
Pageof 2